| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Subscription receivable | 3,087 | - | ||
| Total current assets | 11,947 | 4,590 | ||
| Other assets | 243 | 248 | ||
| Ppe | 93 | - | ||
| Nrx Segment | 23 | - | ||
| Dura Segment | 1 | - | ||
| Less accumulated depreciation | 24 | - | ||
| Furniture and equipment, net | 69 | - | ||
| Right-of-use assets, net-Nonrelated Party | 107 | - | ||
| Right-of-use assets, net-Related Party | 243 | - | ||
| Intangible assets, net | 1,777 | - | ||
| Goodwill | 610 | - | ||
| Total assets | 14,996 | 4,838 | ||
| Total stockholders deficit | -25,755 | -35,615 | ||
| Total liabilities and stockholders' deficit | 14,996 | 4,838 | ||
NRX Pharmaceuticals, Inc. (NRXP)
NRX Pharmaceuticals, Inc. (NRXP)